SWA
CYTK icon

Sutton Wealth Advisors’s Cytokinetics CYTK Stock Holding History

Sutton Wealth Advisors’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,047
Closed -$93.8K – 1000
2022
Q4 		$93.8K Buy
2,047
+1
+0% +$43 0.04% 258
2022
Q3 		$99.1K Buy
2,046
+5
+0.2% +$241 0.04% 249
2022
Q2 		$80.2K Sell
2,041
-4
-0.2% -$161 0.03% 274
2022
Q1 		$75.3K Sell
2,045
-1
-0% -$36 0.03% 305
2021
Q4 		$93.3K Buy
2,046
+20
+1% +$772 0.03% 273
2021
Q3 		$72.4K Hold
2,026
– – 0.03% 297
2021
Q2 		$40.1K Hold
2,026
– – 0.01% 472
2021
Q1 		$47.1K Hold
2,026
– – 0.02% 407
2020
Q4 		$42.1K Hold
2,026
– – 0.02% 409
2020
Q3 		$43.9K Sell
2,026
-24
-1% -$561 0.02% 327
2020
Q2 		$48.3K Sell
2,050
-161
-7% -$3.02K 0.03% 308
2020
Q1 		$26.1K Hold
2,211
– – 0.02% 403
2019
Q4 		$23.5K Hold
2,211
– – 0.01% 537
2019
Q3 		$25.2K Hold
2,211
– – 0.01% 502
2019
Q2 		$24.9K Hold
2,211
– – 0.01% 506
2019
Q1 		$17.9K Buy
+2,211
New +$16.3K 0.01% 617
2018
Q4 		– Sell
-961
Closed -$9.47K – 1144
2018
Q3 		$9.47K Buy
+961
New +$7.71K 0.01% 795
2017
Q4 		– Sell
-624
Closed -$9.05K – 1084
2017
Q3 		$9.05K Buy
624
+80
+15% +$1.09K 0.01% 781
2017
Q2 		$6.58K Buy
+544
New +$7.56K 0.01% 832

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Sutton Wealth Advisors's CYTK Position: Q1 2023 in Review

Sutton Wealth Advisors sold out of Cytokinetics (CYTK) in Q1 2023, closing a stake of 2,047 shares — an estimated $93.8K sold.

Sutton Wealth Advisors first reported a position in CYTK in Q2 2017 and held it in 19 quarters. The position peaked at $99.1K in Q3 2022. 262 funds tracked by Wall St. Rank hold CYTK as of Q1 2023.

  • Sutton Wealth Advisors reported no remaining Cytokinetics position as of Q1 2023 after selling out during the quarter.
  • Sutton Wealth Advisors sold 2,047 Cytokinetics shares in Q1 2023, an estimated $93.8K.
  • Sutton Wealth Advisors first reported a position in Cytokinetics in Q2 2017 and held it in 19 quarters.
  • Sutton Wealth Advisors's Cytokinetics position peaked at $99.1K in Q3 2022.
  • 262 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2023.

Based on Sutton Wealth Advisors's 13F filing for Q1 2023, filed 7 Nov 2023.